Difelikefalin-associated adverse drug event signals: a real-world pharmacovigilance study from the FAERS database
{{output}}
Background and objective: Difelikefalin, a peripherally acting selective κ-opioid receptor agonist, is approved for treating chronic kidney disease-associated pruritus (CKD-aP) in adults on hemodialysis. However, real-world data... ...
